- Author:
Eun Kyo JUNG
1
;
Ji Young CHANG
;
Yoon Pyo LEE
;
Min Kyung CHUNG
;
Eui Kyo SEO
;
Hea Soo KOO
;
Hee Jung CHOI
Author Information
- Publication Type:Case Report
- Keywords: Mycobacterium tuberculosis; Tuberculosis, multidrug-resistant; Tuberculosis, central nervous system; Tuberculosis, pulmonary
- MeSH: Biopsy; Brain*; China; Cycloserine; Emigrants and Immigrants; Female; Headache; Humans; Kanamycin; Korea; Linezolid; Lung; Mycobacterium tuberculosis; Prothionamide; Streptomycin; Tuberculoma, Intracranial; Tuberculosis, Central Nervous System; Tuberculosis, Multidrug-Resistant*; Tuberculosis, Pulmonary; Young Adult
- From:Infection and Chemotherapy 2016;48(1):41-46
- CountryRepublic of Korea
- Language:English
- Abstract: We report a case of a 23-year-old female immigrant from China who was diagnosed with multidrug-resistant tuberculosis affecting her lung and brain, resistant to the standard first-line therapeutics and streptomycin. She was treated with prothionamide, moxifloxacin, cycloserine, and kanamycin. However, her headache and brain lesion worsened. After the brain biopsy, the patient was confirmed with intracranial tuberculoma. Linezolid was added to intensify the treatment regimen, and steroid was added for the possibility of paradoxical response. Kanamycin was discontinued 6 months after initiation of the treatment; she was treated for 18 months with susceptible drugs and completely recovered. To our knowledge, this case is the first multidrug-resistant tuberculosis that disseminated to the brain in Korea.